Heraeus expands its platinum-based HPAPI capacity
21 Nov 2019Company's multimillion euro investment will enable it to meet growing market demands from clients providing cancer treatments.
Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for platinum-based highly potent active pharmaceutical ingredients (HPAPIs) with an additional production line built at the company’s headquarters in Hanau, Germany.

Heraeus is the leading market supplier for Platinum-based HPAPIs, which are a key component used in cancer chemotherapy. As cancer cases rise across the globe, Heraeus has increased its production capabilities to ensure it leads the drive for much-needed capacity to meet the long-term global market demand.
The technical set-up of the new production line is now complete and commercial production is scheduled to begin in 2020 upon completion of the validation process.
Dr Marcus Hannakam, Head of Heraeus’ Pharmaceutical Ingredients Business Line said: “This multimillion euro investment in additional capacity underlines our commitment to lead in this field and help our customers in the vital job of providing the drugs to treat cancer patients across the globe.
“We have a proud tradition in high-quality precious metal technologies and a continued focus on fostering long-term partnerships with our customers who work on therapies to fight cancer.
“With the technical set-up of our new production line now complete, we are primed and ready to meet the growing market demands from our clients for platinum-based HPAPIs and lifesaving treatments for cancer patients.”
Platinum-based HPAPIs are used in chemotherapy treatments to combat a range of cancers, including lung, colorectal, ovarian and testicular cancer. The need for these particular HPAPIs in cancer treatment has been rocketing due to demographic changes leading to more cancer cases, emerging countries gaining access to chemotherapy and usage of platinum-based HPAPIs in combination therapy.
Related news
.jpg)
Catalent to Partner with Ethicann on new fast-dissolve cannabinoid-based treatment
4 Dec 2019
Program will initially focus on using Catalent’s orally disintegrating tablet technology to develop a combination pharmaceutical-grade CBD and THC product that, if approved, would treat patients suffering from MS spasticity.
Read more.jpg)
Connectivity, customization and sustainability driving packaging and drug delivery in 2020
4 Dec 2019
Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.
Read more.jpg)
Eli Lilly unveils shared innovation laboratory in San Francisco
3 Dec 2019
Lilly Gateway Labs will provide biotech companies direct access to Lilly scientists and expertise.
Read more.jpg)
Ground-breaking work creates novel oil-in-water nanoemulsions
3 Dec 2019
New innovation has considerable potential to be used as a new environmentally friendly matrix for the microencapsulation and controlled release of a wide range of actives.
Read more.jpg)
UK experiences a 'baby boom' of new life sciences ventures
2 Dec 2019
Unprecedented levels of investment cited as a major force driving the expansion.
Read more.jpg)
Pinpoint secures new investment to develop "ground-breaking" products
29 Nov 2019
The financial backing will help the company to develop a new generation of microbial air monitors that enables continuous monitoring as demanded by the Annex 1 revision.
Read more.jpg)
New single-use mixing system offers rapid and homogenous mixing
28 Nov 2019
ClearMixx performs liquid/liquid and powder/liquid mixing, with a dispersion plate able to efficiently mix the most challenging buffer, media and biopharmaceutical ingredients.
Read more.jpg)
Worldwide event predicts global pharma trends for 2020
27 Nov 2019
Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.
Read more
UK’s life sciences sector continues to attract talent despite Brexit fear
26 Nov 2019
The largest area of growth has been within biotechnology companies, where job openings increased by 35%.
Read more
Dr Reddy’s enters Nutrition Segment with diabetes drink
25 Nov 2019
The company's diabetes nutrition drink, Celevida, is formulated to help manage blood glucose levels.
Read moreAre you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation